Volk David E, Lokesh Ganesh L R
McGovern Medical School, Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas Health Science Center, Houston, TX 77030, USA.
Biomedicines. 2017 Jul 13;5(3):41. doi: 10.3390/biomedicines5030041.
Nucleic acid aptamers are short RNA- or DNA-based affinity reagents typically selected from combinatorial libraries to bind to a specific target such as a protein, a small molecule, whole cells or even animals. Aptamers have utility in the development of diagnostic, imaging and therapeutic applications due to their size, physico-chemical nature and ease of synthesis and modification to suit the application. A variety of oligonucleotide modifications have been used to enhance the stability of aptamers from nuclease degradation in vivo. The non-bridging oxygen atoms of the phosphodiester backbones of RNA and DNA aptamers can be substituted with one or two sulfur atoms, resulting in thioaptamers with phosphorothioate or phosphorodithioate linkages, respectively. Such thioaptamers are known to have increased binding affinity towards their target, as well as enhanced resistance to nuclease degradation. In this review, we discuss the development of phosphorothioate chemistry and thioaptamers, with a brief review of selection methods.
核酸适体是基于RNA或DNA的短亲和试剂,通常从组合文库中筛选出来,以结合特定靶标,如蛋白质、小分子、全细胞甚至动物。由于其大小、物理化学性质以及易于合成和修饰以适应应用,适体在诊断、成像和治疗应用的开发中具有实用性。多种寡核苷酸修饰已被用于提高适体在体内抵抗核酸酶降解的稳定性。RNA和DNA适体的磷酸二酯主链的非桥连氧原子可以被一个或两个硫原子取代,分别产生具有硫代磷酸酯或二硫代磷酸酯键的硫代适体。已知此类硫代适体对其靶标的结合亲和力增加,并且对核酸酶降解的抗性增强。在本综述中,我们讨论硫代磷酸酯化学和硫代适体的发展,并简要回顾筛选方法。